"Currently, doctors have to make an educated guess as to what might be effective at clearing a clot then they check their theory afterwards," Leslie-Mazwi says. "The drawback to this is that every patient is different and what might work in one could have life-threatening consequences in another."
Leslie-Mazwi says Grinberg's work proves the feasibility of computer simulations that could determine beforehand whether or not specific treatments would have the desired effect. He adds that the technology could have big financial implications in the medical field as well, especially for drug companies. "Drug companies spend billions trying to develop products that end up not making it through clinical testing," he says. "A multi-scale algorithm could be tailored to show what works and what doesn't. It would give you the ability to predict your investment.”